P01.10 METABOLIC CONDITIONS DETERMINE SENSITIVITY OF GLIOMA CELLS AGAINST EPIDERMAL-GROWTH FACTOR RECEPTOR (EGFR)-INHIBITION

Por Hartel, I.A., Wolking, S., Wanka, C., Ronellenfitsch, M.W., Steinbach, J.P., Rieger, J.
Publicado em 2014

P01.11 The transcriptional coactivator PGC-1a promotes defence against reactive oxygen species (ROS) and proliferation in human glioma cells

Por Hartel, I., Sauer, B., Burger, M., Ronellenfitsch, M. W., Steinbach, J. P., Rieger, J.
Publicado no Neuro Oncol (2016)

P06.05 Myoinositol as a predictive baseline biomarker for overall survival of patients with recurrent glioblastoma treated with Bevacizumab: A 1H-magnetic resonance spectroscopy st...

Por Steidl, E., Pilatus, U., Steinbach, J. P., Zanella, F., Ronellenfitsch, M. W., Hattingen, E., Bähr, O.
Publicado no Neuro Oncol (2016)

OS1.4 Current treatment regimens induce the mTORC1 inhibitor REDD1 in human glioblastoma cells: implications for treatment efficacy

Por Foltyn, M., Thiepold, A., Harter, P. N., Baumgarten, P., Mittelbronn, M., Urban, H., Steinbach, J. P., Ronellenfitsch, M. W.
Publicado no Neuro Oncol (2016)

P04.24 MTOR signaling in glioma-associated microglia and macrophages

Por Zeiner, P S, Lorenz, N I, Burger, M, Luger, A L, Harter, P N, Steinbach, J P, Ronellenfitsch, M W
Publicado no Neuro Oncol (2018)

P04.47 Nrf2 mediates hypoxic tolerance in human glioblastoma cells

Por Lorenz, N I, Luger, A, Zeiner, P S, Engel, A L, Harter, P N, Steinbach, J P, Ronellenfitsch, M W
Publicado no Neuro Oncol (2018)

P01.03 mTORC1 activation sensitizes human malignant glioma cells to hypoxia-induced cell death by increasing O2-consumption

Por Thiepold, A. L., Foltyn, M., Urban, H., Heller, S., Dröse, S., Harter, P. N., Mittelbronn, M., Steinbach, J. P., Ronellenfitsch, M. W.
Publicado no Neuro Oncol (2016)

P01.31 Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death

Por Thiepold, A., Foltyn, M., Urban, H., Voss, M., Hofmann, U., Dröse, S., Harter, P. N., Mittelbronn, M., Steinbach, J. P., Ronellenfitsch, M. W.
Publicado no Neuro Oncol (2017)

P04.50 Doxycycline impairs mitochondrial function and protects human glioma cells from hypoxia-induced cell death: implications of using Tet-inducible systems

Por Sauer, B, Luger, A, Lorenz, N I, Engel, A L, Braun, Y, Voss, M, Harter, P N, Steinbach, J P, Ronellenfitsch, M W
Publicado no Neuro Oncol (2018)

P03.21 Casp9 germline mutation in a family with multiple brain tumors

Por Ronellenfitsch, M. W., Oh, J., Satomi, K., Sumi, K., Harter, P. N., Steinbach, J. P., Felsberg, J., Capper, D., Voegele, C., Schittenhelm, J., Mittelbronn, M., Ohgaki, H.
Publicado no Neuro Oncol (2017)

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival

Por Zeiner, P. S., Zinke, J., Kowalewski, D. J., Bernatz, S., Tichy, J., Ronellenfitsch, M. W., Thorsen, F., Berger, A., Forster, M. T., Muller, A., Steinbach, J. P., Beschorner, R., Wischhusen, J., Kvasnicka, H. M., Plate, K. H., Stefanović, S., Weide, B., Mittelbronn, M., Harter, P. N.
Publicado no Acta Neuropathol Commun (2018)